Search results for "expression"

showing 10 items of 5168 documents

Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

2012

Background: New therapeutic options for metastatic pancreatic cancer are urgently needed. In pancreatic cancer, overexpression of the epidermal growth factor receptor 2 (HER2) has been reported in up to 45%. This multicentre phase II study investigated the efficacy and toxicity of the HER2 antibody trastuzumab combined with capecitabine in the patients with pancreatic cancer and HER2 overexpression. Methods: Primary endpoint was progression-free survival (PFS) after 12 weeks. A total of 212 patients were screened for HER2 expression. Results: Immunohistochemical (IHC) HER2 expression was: 83 (40%) grade 0, 71 (34%) grade 1, 31 (15%) grade 2, 22 (11%) grade 3. A total of 17 patients with IHC…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyReceptor ErbB-2medicine.medical_treatmentpancreatic cancerGene ExpressionPhases of clinical researchKaplan-Meier EstimateAdenocarcinomaAntibodies Monoclonal HumanizedchemotherapyDeoxycytidineDisease-Free SurvivalCapecitabineTrastuzumabInternal medicinePancreatic cancerAntineoplastic Combined Chemotherapy Protocolsgrowth factorsmedicineHumansskin and connective tissue diseasesneoplasmsCapecitabineAgedChemotherapybusiness.industryCancerMiddle AgedTrastuzumabmedicine.diseasePancreatic NeoplasmsTreatment OutcomeOncologyFluorouracilimmunohistochemistryClinical StudyAdenocarcinomaFemaleFluorouracilbusinessmedicine.drugBritish Journal of Cancer
researchProduct

High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer

2020

Abstract Background The cell surface interleukin 22 (IL-22) receptor complex is mainly expressed in epithelial and tissue cells like pancreatitis cells. Recent studies described that IL-22R was overexpressed in malignant diseases and was associated with a poor overall survival (OS). The role of IL-22RA1 gene expression in muscle invasive bladder cancer (MIBC) has not been investigated, yet. Objectives The aim of this study was to analyze the role of IL-22RA1 gene expression in patients with MIBC. Methods In a cohort of 114 patients with MIBC who underwent radical cystectomy, IL-22RA1 gene expression was analyzed with qRT-PCR and correlated with clinical parameters. Furthermore, Kaplan-Meier…

AdultMaleOncologymedicine.medical_specialtyReceptor complexUrologymedicine.medical_treatment030232 urology & nephrologyCystectomyCohort StudiesCystectomyInterleukin 2203 medical and health sciences0302 clinical medicineInternal medicineGene expressionBiomarkers TumormedicineHumansNeoplasm InvasivenessAgedAged 80 and overMuscle NeoplasmsBladder cancerProportional hazards modelbusiness.industryReceptors InterleukinMiddle AgedPrognosismedicine.diseaseSurvival RateUrinary Bladder NeoplasmsOncology030220 oncology & carcinogenesisCohortT-stageFemalebusinessFollow-Up StudiesUrologic Oncology: Seminars and Original Investigations
researchProduct

Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflamma…

2010

OBJECTIVES: Subclinical gut inflammation has been demonstrated in patients with AS. Altered expression of paneth cell (PC) anti-microbial peptides have been reported in the inflamed ileum of patients with Crohn's disease (CD). Here, we investigated the expression of PC-derived peptides in subclinical gut inflammation in AS. METHODS: Multiple adjacent mucosal biopsies from terminal ileum were obtained from 25 patients with AS, 30 CD and 15 healthy controls (HCs). Expression of human α-defensin 5 (HD-5), phospholipase A2 (PLA2), lysozyme and SOX-9 molecules was assessed by quantitative Taqman RT-PCR on mucosal samples. Immunohistochemistry with anti-human HD-5 antibody and genotyping of relev…

AdultMalePaneth CellsPathologymedicine.medical_specialtyGene ExpressionInflammationIleumdigestive systemRheumatologyNOD2ankylosing spondylitismedicineHumansSpondylitis AnkylosingPharmacology (medical)IleitisPrecordial catch syndromeSubclinical infectionPaneth cellInnate immune systembusiness.industryMiddle Agedmedicine.diseaseGastroenteritisPaneth cells alpha-defensin ankylosing spondylitismedicine.anatomical_structureCase-Control StudiesPaneth cellImmunologyalpha-defensinFemalemedicine.symptombusinessAntimicrobial Cationic PeptidesRheumatology
researchProduct

Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

2009

Objective Subclinical gut inflammation is common in spondylarthritis, but the immunologic abnormalities underlying this process are undefined. Perturbation of the interleukin-23 (IL-23)/Th17 axis has emerged as a fundamental trigger of chronic inflammation. This study was undertaken to investigate the expression and tissue distribution of IL-23/Th17–related molecules in Crohn's disease (CD) and in subclinical gut inflammation in ankylosing spondylitis (AS). Methods Quantitative gene expression analysis of Th1/Th2 and IL-23/Th17 responses was performed in intestinal biopsy samples obtained from 12 patients with CD, 15 patients with AS, and 13 controls. IL-23 tissue distribution and identific…

AdultMalePaneth Cellschronic inflammationPathologymedicine.medical_specialtyImmunologyGene ExpressionInflammationMonocytesTh2 CellsRheumatologyIntestinal mucosaIleumankylosing spondylitisPrevalencemedicineInterleukin 23HumansImmunology and Allergyinterleukin-23 (IL-23); Th 17;chronic inflammation; Crohn's disease; ankylosing spondylitisSpondylitis AnkylosingPharmacology (medical)IleitisRNA MessengerIntestinal MucosaSpondylitisinterleukin-23 (IL-23)Subclinical infectionAnkylosing spondylitisbusiness.industryInterleukin-17IleitisMiddle AgedTh1 Cellsmedicine.diseaseUp-RegulationCrohn's diseaseSTAT1 Transcription FactorTh 17ImmunologyInterleukin-23 Subunit p19FemaleInterleukin 17medicine.symptombusinessArthritis & Rheumatism
researchProduct

Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methy…

2013

The scaffold protein A-kinase anchor protein 12 (AKAP12) exerts tumor suppressor activity and is downregulated in several tumor entities. We characterized AKAP12 expression and regulation in astrocytomas, including pilocytic and diffusely infiltrating astrocytomas. We examined 194 human gliomas and 23 normal brain white matter samples by immunohistochemistry or immunoblotting for AKAP12 expression. We further performed quantitative methylation analysis of the AKAP12 promoter by MassARRAY® of normal brain, World Health Organization (WHO) grade I to IV astrocytomas, and glioma cell lines. Our results show that AKAP12 is expressed in a perivascular distribution in normal CNS, strongly upregula…

AdultMalePathologymedicine.medical_specialtyAdolescent2804 Cellular and Molecular NeuroscienceA Kinase Anchor ProteinsCell Cycle Proteins610 Medicine & healthAstrocytomaBiologyPathology and Forensic MedicineCellular and Molecular NeuroscienceGliomamedicineHumansChildPromoter Regions GeneticneoplasmsAgedAged 80 and overRegulation of gene expressionPilocytic astrocytomaBrain NeoplasmsInfantAstrocytomaGeneral MedicineMethylationDNA MethylationMiddle AgedAKAP12medicine.diseaseUp-Regulationnervous system diseases10040 Clinic for NeurologyGene Expression Regulation Neoplastic2734 Pathology and Forensic Medicine2728 Neurology (clinical)nervous systemNeurologyChild Preschool2808 NeurologyDNA methylationCancer researchImmunohistochemistryFemaleNeurology (clinical)Neoplasm Grading
researchProduct

Primordial odontogenic tumor : a systematic review

2019

Background The primordial odontogenic tumor (POT) is a recently described benign entity with histopathological and immunohistochemical features suggesting its origin during early odontogenesis. Aim: To integrate the available data published on POT into a comprehensive analysis to better define its clinicopathological and molecular features. Material and Methods An electronic systematic review was performed up to September 2019 in multiple databases. Results A total of 13 publications were included, representing 16 reported cases and 3 molecular studies. The mean age of the affected patients was 11.6 years (range 2-19), with a slight predominance in males (56.25%). The posterior mandible was…

AdultMalePathologymedicine.medical_specialtyAdolescentCD34VimentinOdontogenic TumorsMandibleReviewEpitheliumLesionVariable Expression03 medical and health sciencesYoung Adult0302 clinical medicineSurvivinmedicineHumansPrimordial odontogenic tumorChildGeneral DentistryOral Medicine and Pathologybiologybusiness.industryOdontogenic tumor030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseasestomatognathic diseasesOtorhinolaryngologyChild PreschoolUNESCO::CIENCIAS MÉDICASbiology.proteinSystematic reviewImmunohistochemistryOdontogenesisSurgerymedicine.symptomAmelogeninNeoplasm Recurrence Localbusiness
researchProduct

Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.

2012

Background : Chronic rhinosinusitis (CRS) is an inflammation of the nose and of the paranasal sinuses. The involvement of the respiratory epithelium in the mechanisms of CRS is poorly understood. Aims : Among proteins expressed by nasal epithelial cells in CRS, IL-19 may have key functions. We here aimed to determine the expression and regulation of IL-19. Methods : Nasal biopsies from normal subjects (n = 12), subjects with CRS but without nasal polyps (NP) (CRSsNP, n = 12) and with CRS with NP (CRSwNP, n = 15) were collected. Human Asthma Gene Array and real-time PCR were used to evaluate gene expression, western blot analysis and immunohistochemistry for protein expression. Results for I…

AdultMalePathologymedicine.medical_specialtyAdolescentImmunologyGene ExpressionMucous membrane of noseYoung AdultInterleukin 20Nasal Polypsotorhinolaryngologic diseasesImmunology and AllergyMedicineHumansNasal polypsRNA MessengerSinusitisSinusitisAsthma inflammation nasal polyps rhinitisRhinitisbusiness.industryGene Expression ProfilingInterleukinsEpithelial CellsMiddle Agedmedicine.diseaseEpitheliumGene expression profilingNasal Mucosamedicine.anatomical_structureParanasal sinusesKi-67 AntigenImmunologyChronic DiseaseRespiratory epitheliumFemalebusinessAllergy
researchProduct

Low SPINK5 expression in chronic rhinosinusitis

2012

Objectives/Hypothesis: Chronic rhinosinusitis (CRS) is a multifactorial disease that probably arises as a result of genetic diversity and environmental factors. SPINK5 is a serine protease inhibitor, which is supposed to be an important regulator of epithelial barrier maintenance. The role of SPINK5 polymorphisms and expression in CRS, especially in individuals with aspirin intolerance, is unclear. Study Design: SPINK5 single-nucleotide polymorphisms (SNPs) and SPINK5 expression levels were correlated with CRS without (CRSsNP) and with nasal polyps (CRSwNP), aspirin intolerance, asthma, and allergies. Methods: One hundred four nasal tissue samples, 15 from patients with CRSsNP, 59 from pati…

AdultMalePathologymedicine.medical_specialtyAllergyAdolescentGenotypeProteinase Inhibitory Proteins SecretorySingle-nucleotide polymorphismPolymerase Chain ReactionPolymorphism Single NucleotideSensitivity and SpecificitySampling Studieslaw.inventionDrug HypersensitivityTissue Culture TechniquesYoung AdultNasal PolypsReference ValueslawGenotypemedicineHumansSNPNasal polypsRNA MessengerSinusitisPolymerase chain reactionAgedRhinitisAsthmaAged 80 and overAspirinbusiness.industryMiddle Agedmedicine.diseaseAsthmaPathophysiologyNasal MucosaGene Expression RegulationOtorhinolaryngologyChronic DiseaseImmunologySerine Peptidase Inhibitor Kazal-Type 5FemalebusinessThe Laryngoscope
researchProduct

Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.

1998

Helicobacter pylori infection is associated with chronic gastritis, peptic ulceration, and gastric carcinoma. The potential role of CD95-mediated apoptosis was investigated in a panel of gastric biopsies obtained from patients with H. pylori-associated chronic gastritis (n = 29) and with noninfected normal mucosa (n = 10). Immunohistochemistry revealed increased CD95 receptor expression in epithelial and lamina propria cells in chronic gastritis. By in situ hybridization, CD95 ligand mRNA was absent or low in normal mucosa but expressed at high levels in lamina propria lymphocytes and, unexpectedly, in epithelial cells in chronic gastritis. Apoptotic cells were rare in normal mucosa but wer…

AdultMalePathologymedicine.medical_specialtyFas Ligand ProteinBiopsyReceptor expressionChronic gastritisApoptosisBiologyCell LineHelicobacter InfectionsIn Situ Nick-End LabelingPyloric AntrumTumor Cells CulturedmedicineGastric mucosaHumansCytotoxic T cellRNA Messengerfas ReceptorAgedAged 80 and overLamina propriaMembrane GlycoproteinsHelicobacter pyloriEpithelial CellsGeneral MedicineMiddle AgedHelicobacter pyloriFas receptorbiology.organism_classificationmedicine.diseaseMolecular biologyUp-Regulationmedicine.anatomical_structureGastric MucosaGastritisChronic DiseaseFemaleGastritismedicine.symptomResearch ArticleJournal of Clinical Investigation
researchProduct

Oncogene overexpression in non-small-cell lung cancer tissue: prevalence and clinicopathological significance.

1994

In contrast to small-cell lung cancer, few data are available on the role of oncogene overexpression in non-small-cell lung cancers (NSCLC). To determine the prevalence and extent of the transcriptional activation of cancer genes in NSCLC we investigated the level of mRNA of the three important cellular oncogenes — erbB2, Ki-ras, and c-myc — in 39 surgically or endoscopically obtained tumor samples and 24 samples of normal bronchopulmonary tissue taken from the same patients. Tissue RNA was prepared and the specific mRNA analyzed by the highly sensitive nuclease S1 protection assay. Oncogene mRNA in the tumors was quantified by comparison with the homogeneously weak signals in normal lung t…

AdultMalePathologymedicine.medical_specialtyLung NeoplasmsAdolescentBiologyCarcinoma Non-Small-Cell LungDrug DiscoveryGene expressionmedicineCarcinomaHumansLung cancerGenetics (clinical)AgedAged 80 and overMessenger RNAOncogeneCancerOncogenesMiddle Agedmedicine.diseaseMolecular medicineGene Expression Regulation NeoplasticCancer researchMolecular MedicineAdenocarcinomaFemaleThe Clinical investigator
researchProduct